LAMEA Fusion Biopsy Market By End Use (Diagnostic centers, Hospitals and Ambulatory care centers), By Route (Transperineal and Transrectal), By Country, Industry Analysis and Forecast, 2020 - 2026
The Latin America, Middle East and Africa Fusion Biopsy Market would witness market growth of 12.3% CAGR during the forecast period (2020-2026).
The growing incidence of prostate cancer, increasing adoption of multiparametric MRI in prostate cancer treatment and care along with greater specificity of fusion biopsy are some of the factors that are expected to drive the targeted MR/Ultrasound biopsy system demand in the coming years. According to several studies, the success rate of prostate biopsy combined with traditional core biopsy is about 33%, while the MR/US fusion biopsy has the success rate ranging from 58-70%. Thus, the need for a repeat biopsy is eliminated by fusion biopsy and therefore minimizes additional healthcare costs and patient discomfort.
At times, it is hard to detect prostate cancer and fusion biopsy is very beneficial in this. The Fusion Biopsy System Market is likely to grow globally at a significant CAGR in the forecast period because of the fact that the scope, product types, and applications of these products are continuously increasing across the globe. A Fusion biopsy system combines MRI ultrasound along with biopsy system for a better view. Fusion biopsy is also termed as fusion guided biopsy. Moreover, biopsy infers taking the tissue sample from the body then examines the report and detect it in the best possible manner. When test previously done in case of any prostrate related problems and if that test shows an anomaly in certain areas of the sample; then doctors recommend for biopsy.
Based on End Use, the market is segmented into Diagnostic centers, Hospitals and Ambulatory care centers. Based on Route, the market is segmented into Transperineal and Transrectal. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Hitachi, Ltd., Baxter International, Inc. (MedCom), Esaote SpA, Eigen, KOELIS, Inc., Focal Healthcare, Inc. and UC-Care Medical Systems Ltd.
Scope of the Study
Market Segmentation:
By End Use
The growing incidence of prostate cancer, increasing adoption of multiparametric MRI in prostate cancer treatment and care along with greater specificity of fusion biopsy are some of the factors that are expected to drive the targeted MR/Ultrasound biopsy system demand in the coming years. According to several studies, the success rate of prostate biopsy combined with traditional core biopsy is about 33%, while the MR/US fusion biopsy has the success rate ranging from 58-70%. Thus, the need for a repeat biopsy is eliminated by fusion biopsy and therefore minimizes additional healthcare costs and patient discomfort.
At times, it is hard to detect prostate cancer and fusion biopsy is very beneficial in this. The Fusion Biopsy System Market is likely to grow globally at a significant CAGR in the forecast period because of the fact that the scope, product types, and applications of these products are continuously increasing across the globe. A Fusion biopsy system combines MRI ultrasound along with biopsy system for a better view. Fusion biopsy is also termed as fusion guided biopsy. Moreover, biopsy infers taking the tissue sample from the body then examines the report and detect it in the best possible manner. When test previously done in case of any prostrate related problems and if that test shows an anomaly in certain areas of the sample; then doctors recommend for biopsy.
Based on End Use, the market is segmented into Diagnostic centers, Hospitals and Ambulatory care centers. Based on Route, the market is segmented into Transperineal and Transrectal. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Hitachi, Ltd., Baxter International, Inc. (MedCom), Esaote SpA, Eigen, KOELIS, Inc., Focal Healthcare, Inc. and UC-Care Medical Systems Ltd.
Scope of the Study
Market Segmentation:
By End Use
- Diagnostic centers
- Hospitals
- Ambulatory care centers
- Transperineal
- Transrectal
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
- Koninklijke Philips N.V.
- Hitachi, Ltd.
- Baxter International, Inc. (MedCom)
- Esaote SpA
- Eigen
- KOELIS, Inc.
- Focal Healthcare, Inc.
- UC-Care Medical Systems Ltd.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Fusion Biopsy Market, by End Use
1.4.2 LAMEA Fusion Biopsy Market, by Route
1.4.3 LAMEA Fusion Biopsy Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. RECENT MARKET DEVELOPMENTS IN FUSION BIOPSY MARKET
CHAPTER 4. LAMEA FUSION BIOPSY MARKET BY END USES
4.1 LAMEA Diagnostic centers Market by Country
4.2 LAMEA Hospitals Market by Country
4.3 LAMEA Ambulatory care centers Market by Country
CHAPTER 5. LAMEA FUSION BIOPSY MARKET BY ROUTE
5.1 LAMEA Transperineal Market by Country
5.2 LAMEA Transrectal Market by Country
CHAPTER 6. LAMEA FUSION BIOPSY MARKET BY COUNTRY
6.1 Brazil Fusion Biopsy Market
6.1.1 Brazil Fusion Biopsy Market by End Uses
6.1.2 Brazil Fusion Biopsy Market by Route
6.2 Argentina Fusion Biopsy Market
6.2.1 Argentina Fusion Biopsy Market by End Uses
6.2.2 Argentina Fusion Biopsy Market by Route
6.3 UAE Fusion Biopsy Market
6.3.1 UAE Fusion Biopsy Market by End Uses
6.3.2 UAE Fusion Biopsy Market by Route
6.4 Saudi Arabia Fusion Biopsy Market
6.4.1 Saudi Arabia Fusion Biopsy Market by End Uses
6.4.2 Saudi Arabia Fusion Biopsy Market by Route
6.5 South Africa Fusion Biopsy Market
6.5.1 South Africa Fusion Biopsy Market by End Uses
6.5.2 South Africa Fusion Biopsy Market by Route
6.6 Nigeria Fusion Biopsy Market
6.6.1 Nigeria Fusion Biopsy Market by End Uses
6.6.2 Nigeria Fusion Biopsy Market by Route
6.7 Rest of LAMEA Fusion Biopsy Market
6.7.1 Rest of LAMEA Fusion Biopsy Market by End Uses
6.7.2 Rest of LAMEA Fusion Biopsy Market by Route
CHAPTER 7. COMPANY PROFILES
7.1 Koninklijke Philips N.V.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.2 Hitachi, Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Baxter International, Inc. (MedCom)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.4 Esaote SpA
7.4.1 Company Overview
7.5 Eigen
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 KOELIS, Inc.
7.6.1 Company Overview
7.7 Focal Healthcare, Inc.
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Approvals:
7.8 UC-Care Medical Systems Ltd.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Partnerships, Collaborations, and Agreements:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Fusion Biopsy Market, by End Use
1.4.2 LAMEA Fusion Biopsy Market, by Route
1.4.3 LAMEA Fusion Biopsy Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. RECENT MARKET DEVELOPMENTS IN FUSION BIOPSY MARKET
CHAPTER 4. LAMEA FUSION BIOPSY MARKET BY END USES
4.1 LAMEA Diagnostic centers Market by Country
4.2 LAMEA Hospitals Market by Country
4.3 LAMEA Ambulatory care centers Market by Country
CHAPTER 5. LAMEA FUSION BIOPSY MARKET BY ROUTE
5.1 LAMEA Transperineal Market by Country
5.2 LAMEA Transrectal Market by Country
CHAPTER 6. LAMEA FUSION BIOPSY MARKET BY COUNTRY
6.1 Brazil Fusion Biopsy Market
6.1.1 Brazil Fusion Biopsy Market by End Uses
6.1.2 Brazil Fusion Biopsy Market by Route
6.2 Argentina Fusion Biopsy Market
6.2.1 Argentina Fusion Biopsy Market by End Uses
6.2.2 Argentina Fusion Biopsy Market by Route
6.3 UAE Fusion Biopsy Market
6.3.1 UAE Fusion Biopsy Market by End Uses
6.3.2 UAE Fusion Biopsy Market by Route
6.4 Saudi Arabia Fusion Biopsy Market
6.4.1 Saudi Arabia Fusion Biopsy Market by End Uses
6.4.2 Saudi Arabia Fusion Biopsy Market by Route
6.5 South Africa Fusion Biopsy Market
6.5.1 South Africa Fusion Biopsy Market by End Uses
6.5.2 South Africa Fusion Biopsy Market by Route
6.6 Nigeria Fusion Biopsy Market
6.6.1 Nigeria Fusion Biopsy Market by End Uses
6.6.2 Nigeria Fusion Biopsy Market by Route
6.7 Rest of LAMEA Fusion Biopsy Market
6.7.1 Rest of LAMEA Fusion Biopsy Market by End Uses
6.7.2 Rest of LAMEA Fusion Biopsy Market by Route
CHAPTER 7. COMPANY PROFILES
7.1 Koninklijke Philips N.V.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.2 Hitachi, Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Baxter International, Inc. (MedCom)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.4 Esaote SpA
7.4.1 Company Overview
7.5 Eigen
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 KOELIS, Inc.
7.6.1 Company Overview
7.7 Focal Healthcare, Inc.
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Approvals:
7.8 UC-Care Medical Systems Ltd.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Partnerships, Collaborations, and Agreements:
LIST OF TABLES
TABLE 1 LAMEA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 2 LAMEA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 3 LAMEA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 4 LAMEA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 5 LAMEA DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 LAMEA DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 LAMEA HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 LAMEA HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 LAMEA AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 LAMEA AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 LAMEA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 12 LAMEA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 13 LAMEA TRANSPERINEAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 LAMEA TRANSPERINEAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 LAMEA TRANSRECTAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 LAMEA TRANSRECTAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 LAMEA FUSION BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 LAMEA FUSION BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 BRAZIL FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 20 BRAZIL FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 21 BRAZIL FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 22 BRAZIL FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 23 BRAZIL FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 24 BRAZIL FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 25 ARGENTINA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 26 ARGENTINA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 27 ARGENTINA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 28 ARGENTINA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 29 ARGENTINA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 30 ARGENTINA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 31 UAE FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 32 UAE FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 33 UAE FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 34 UAE FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 35 UAE FUSION BIOPSY MARKET BY SOURCE, 2016 - 2019, USD MILLION
TABLE 36 UAE FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 37 SAUDI ARABIA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 38 SAUDI ARABIA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 39 SAUDI ARABIA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 40 SAUDI ARABIA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 41 SAUDI ARABIA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 42 SAUDI ARABIA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 43 SOUTH AFRICA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 44 SOUTH AFRICA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 45 SOUTH AFRICA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 46 SOUTH AFRICA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 47 SOUTH AFRICA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 48 SOUTH AFRICA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 49 NIGERIA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 50 NIGERIA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 51 NIGERIA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 52 NIGERIA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 53 NIGERIA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 54 NIGERIA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 55 REST OF LAMEA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 56 REST OF LAMEA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 57 REST OF LAMEA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 58 REST OF LAMEA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 59 REST OF LAMEA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 60 REST OF LAMEA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 61 KEY INFORMATION – KONINKLIJKE PHILIPS N.V.
TABLE 62 KEY INFORMATION – HITACHI, LTD.
TABLE 63 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 64 KEY INFORMATION – ESAOTE SPA
TABLE 65 KEY INFORMATION – EIGEN
TABLE 66 KEY INFORMATION – KOELIS, INC.
TABLE 67 KEY INFORMATION – FOCAL HEALTHCARE, INC.
TABLE 68 KEY INFORMATION – UC-CARE MEDICAL SYSTEMS LTD.
TABLE 1 LAMEA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 2 LAMEA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 3 LAMEA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 4 LAMEA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 5 LAMEA DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 LAMEA DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 LAMEA HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 LAMEA HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 LAMEA AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 LAMEA AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 LAMEA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 12 LAMEA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 13 LAMEA TRANSPERINEAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 LAMEA TRANSPERINEAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 LAMEA TRANSRECTAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 LAMEA TRANSRECTAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 LAMEA FUSION BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 LAMEA FUSION BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 BRAZIL FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 20 BRAZIL FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 21 BRAZIL FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 22 BRAZIL FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 23 BRAZIL FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 24 BRAZIL FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 25 ARGENTINA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 26 ARGENTINA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 27 ARGENTINA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 28 ARGENTINA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 29 ARGENTINA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 30 ARGENTINA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 31 UAE FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 32 UAE FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 33 UAE FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 34 UAE FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 35 UAE FUSION BIOPSY MARKET BY SOURCE, 2016 - 2019, USD MILLION
TABLE 36 UAE FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 37 SAUDI ARABIA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 38 SAUDI ARABIA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 39 SAUDI ARABIA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 40 SAUDI ARABIA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 41 SAUDI ARABIA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 42 SAUDI ARABIA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 43 SOUTH AFRICA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 44 SOUTH AFRICA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 45 SOUTH AFRICA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 46 SOUTH AFRICA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 47 SOUTH AFRICA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 48 SOUTH AFRICA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 49 NIGERIA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 50 NIGERIA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 51 NIGERIA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 52 NIGERIA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 53 NIGERIA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 54 NIGERIA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 55 REST OF LAMEA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 56 REST OF LAMEA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 57 REST OF LAMEA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 58 REST OF LAMEA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 59 REST OF LAMEA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 60 REST OF LAMEA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 61 KEY INFORMATION – KONINKLIJKE PHILIPS N.V.
TABLE 62 KEY INFORMATION – HITACHI, LTD.
TABLE 63 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 64 KEY INFORMATION – ESAOTE SPA
TABLE 65 KEY INFORMATION – EIGEN
TABLE 66 KEY INFORMATION – KOELIS, INC.
TABLE 67 KEY INFORMATION – FOCAL HEALTHCARE, INC.
TABLE 68 KEY INFORMATION – UC-CARE MEDICAL SYSTEMS LTD.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
